AMTX Aemetis, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
AMTX Stock | Fundamental Analysis & Investment Insights
NASDAQ
Basic Materials
Specialty Chemicals
Current Price
Live
$2.29
Analyst Target
$13.38
+484.1%
Upside
52W High
$3.66
52W Low
$1.22
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
AMTX exhibits weak financial health with a Piotroski F-Score of 4/9, indicating a fragile operational foundation. The absence of an Altman Z-Score and negative profitability metrics—especially a -38.96% profit margin and -8.96% ROA—signal severe operational distress. Despite modest revenue growth (14.20% YoY), the company remains unprofitable and faces liquidity risks with a current ratio of 0.07 and quick ratio of 0.01. The stock trades at a price/sales of 0.77, but this is misleading given the lack of sustainable earnings and negative book value. Analysts' target price of $13.38 appears disconnected from fundamentals, suggesting speculative optimism.
Key Strengths
14.20% year-over-year revenue growth indicates top-line expansion in a challenging sector
Recent quarterly EPS growth (Q/Q: +78.4%, YoY: +77.1%) shows improving earnings momentum
One-time positive earnings surprise in Q1 2023 (+353.9%) suggests potential for recovery
Low market cap ($0.15B) may attract speculative interest and enable rapid price appreciation if fundamentals improve
Positive insider sentiment (40/100) and neutral recent insider activity suggest no major selling pressure
Key Risks
Piotroski F-Score of 4/9 indicates weak financial health and operational instability
Negative profit margin (-38.96%), gross margin (-0.39%), and ROA (-8.96%) reflect deep operational inefficiencies
Extremely weak liquidity: current ratio (0.07) and quick ratio (0.01) imply inability to meet short-term obligations
No Altman Z-Score available, but the financial ratios suggest distress risk; debt/equity and cash levels are missing, increasing uncertainty
No dividend, no free cash flow, and negative book value (Price/Book = -0.49) undermine long-term viability
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare AMTX against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning AMTX from our newsroom.
Newest → oldest
No matching news yet.